
CV Sciences Investor Relations Material
Latest events

Q3 2024
CV Sciences
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from CV Sciences Inc
Access all reports
CV Sciences Inc. is a life sciences company focused on developing and commercializing products derived from hemp-based cannabidiol (CBD). The company's offerings include consumer health products, such as dietary supplements and topical formulations, that promote wellness and support various health needs. CV Sciences operates through two primary segments: consumer products and drug development. The consumer products division produces CBD-based products under the PlusCBD brand, while the drug development segment is involved in researching CBD-based therapeutics. The company is headquartered in San Diego, California, and its shares are listed on the OTCQB.
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
CVSI
Country
🇺🇸 United States